EBA欧洲银行-CY_CXUHEGU3MADZ2CEV7C11_16页_3mb
报告摘要
2014 EU-wide Stress Test Summary for CY - Hellenic Bank Public Company Ltd
Core Information
- Bank Name: CY - Hellenic Bank Public Company Ltd
- LEI Code: CXUHEGU3MADZ2CEV7C11
- Report Date: 31 December 2013
Summary of Adverse Scenario (as of 31 December 2016)
- 3-year cumulative operating profit before impairments: 231 mln EUR
- 3-year cumulative impairment losses on financial and non-financial assets in the banking book: 529 mln EUR
- 3-year cumulative losses from the stress in the trading book: 11 mln EUR
- Valuation losses due to sovereign shock after tax and prudential filters: 0 mln EUR
- Common Equity Tier 1 capital (CET1): -22 mln EUR
- Total Risk Exposure: 4,619 mln EUR
- Common Equity Tier 1 ratio, %: -0.5%
Summary of Baseline Scenario (as of 31 December 2016)
- 3-year cumulative operating profit before impairments: 415 mln EUR
- 3-year cumulative impairment losses on financial and non-financial assets in the banking book: 187 mln EUR
- 3-year cumulative losses from the stress in the trading book: 5 mln EUR
- Common Equity Tier 1 capital (CET1): 431 mln EUR
- Total Risk Exposure: 4,710 mln EUR
- Common Equity Tier 1 ratio, %: 9.1%
Memorandum Items
| Item |
Value (mln EUR) |
| Common EU wide CET1 Threshold (5.5%) |
254 |
| Total amount of instruments with mandatory conversion into ordinary shares (cumulative conversions) |
0 |
| Total Additional Tier 1 and Tier 2 instruments eligible as regulatory capital (convertible or written down) |
253 |
| Of which: eligible instruments whose trigger is above CET1 capital ratio in the adverse scenario |
253 |
Notes
- (1): According to CRR/CRD4 definition with transitional arrangements as per reporting date.
- (2): Conversions not considered for CET1 computation.
- (3): Excluding instruments with mandatory conversion into ordinary shares upon a fixed date in the 2014 - 2016 period.
Risk Exposure Analysis (as of 31 December 2013)
| Category |
F-IRB Exposure |
A-IRB Exposure |
STA Exposure |
| Non-defaulted |
0 |
0 |
0 |
| Defaulted |
0 |
0 |
0 |
| Central banks and central governments |
0 |
0 |
0 |
| Institutions |
0 |
0 |
0 |
| Corporates |
0 |
0 |
0 |
| Corporates - Of Which: Specialised Lending |
0 |
0 |
0 |
| Retail |
0 |
0 |
0 |
| Retail - Secured on real estate property |
0 |
0 |
0 |
| Retail - Secured on real estate property - Of Which: Specialised Lending |
0 |
0 |
0 |
| Retail - Secured on real estate property - Of Which: SME |
0 |
0 |
0 |
| Retail - Secured on real estate property - Of Which: non-SME |
0 |
0 |
0 |
| Retail - Qualifying Revolving |
0 |
0 |
0 |
| Retail - Other Retail |
0 |
0 |
0 |
| Retail - Other Retail - Of Which: SME |
0 |
0 |
0 |
| Retail - Other Retail - Of Which: non-SME |
0 |
0 |
0 |
| Equity |
0 |
0 |
0 |
| Securitisation |
0 |
0 |
0 |
| Other non-credit obligation assets |
0 |
0 |
0 |
| TOTAL |
0 |
0 |
0 |
| Securitisation and re-securitisations positions deducted from capital |
0 |
0 |
0 |
Impairment Rates and Coverage Ratios (Baseline Scenario)
| Year |
Impairment Rate |
Stock of Provisions |
Coverage Ratio - Default Stock |
| 2014 |
0.00% |
0 |
0.00% |
| 2015 |
0.16% |
5 |
52.38% |
| 2016 |
3.40% |
578 |
28.58% |
| 2014 |
0.00% |
0 |
0.00% |
| 2015 |
0.14% |
7 |
48.44% |
| 2016 |
3.26% |
608 |
27.58% |
| 2014 |
0.00% |
0 |
0.00% |
| 2015 |
0.13% |
9 |
46.56% |
| 2016 |
2.91% |
630 |
26.99% |
Impairment Rates and Coverage Ratios (Adverse Scenario)
| Year |
Impairment Rate |
Stock of Provisions |
Coverage Ratio - Default Stock |
| 2014 |
1.85% |
24 |
41.44% |
| 2015 |
1.94% |
48 |
44.75% |
| 2016 |
2.01% |
72 |
48.48% |
| 2014 |
0.18% |
5 |
53.51% |
| 2015 |
0.17% |
8 |
50.28% |
| 2016 |
0.16% |
10 |
48.02% |
| 2014 |
7.34% |
700 |
33.67% |
| 2015 |
7.75% |
765 |
32.88% |
| 2016 |
7.05% |
806 |
32.51% |
| 2014 |
2.25% |
0 |
- |
| 2015 |
2.17% |
0 |
- |
| 2016 |
2.09% |
0 |
- |
| 2014 |
4.08% |
495 |
54.83% |
| 2015 |
4.25% |
537 |
51.76% |
| 2016 |
4.23% |
498 |
49.42% |
| 2014 |
2.67% |
225 |
40.42% |
| 2015 |
2.73% |
244 |
37.64% |
| 2016 |
2.98% |
260 |
35.62% |
| 2014 |
4.10% |
95 |
40.18% |
| 2015 |
4.26% |
103 |
37.48% |
| 2016 |
4.72% |
110 |
35.62% |
| 2014 |
2.07% |
130 |
40.61% |
| 2015 |
2.13% |
141 |
37.76% |
| 2016 |
2.36% |
151 |
35.63% |
| 2014 |
3.56% |
74 |
93.80% |
| 2015 |
3.41% |
78 |
92.32% |
| 2016 |
3.35% |
82 |
91.13% |
| 2014 |
4.60% |
151 |
86.44% |
| 2015 |
4.42% |
159 |
84.13% |
| 2016 |
4.19% |
166 |
82.41% |
| 2014 |
5.28% |
38 |
88.04% |
| 2015 |
5.28% |
40 |
84.65% |
| 2016 |
4.58% |
42 |
82.41% |
| 2014 |
4.42% |
113 |
85.91% |
| 2015 |
4.19% |
119 |
83.95% |
| 2016 |
4.10% |
124 |
82.41% |
Summary of Impairment Rates and Coverage Ratios (Baseline Scenario)
| Year |
Impairment Rate |
Stocks of Pre-Sale |
Coverage Ratio - Default Stock |
| 2014 |
0.00% |
0 |
0.00% |
| 2015 |
0.16% |
5 |
53.33% |
| 2016 |
0.13% |
7 |
47.40% |
| 2014 |
3.40% |
531 |
28.58% |
| 2015 |
3.26% |
608 |
27.58% |
| 2016 |
2.91% |
630 |
26.99% |
| 2014 |
2.25% |
445 |
51.01% |
| 2015 |
2.17% |
468 |
48.85% |
| 2016 |
2.09% |
489 |
47.30% |
| 2014 |
1.33% |
220 |
35.13% |
| 2015 |
1.26% |
231 |
33.32% |
| 2016 |
1.19% |
240 |
32.01% |
| 2014 |
1.24% |
82 |
36.45% |
| 2015 |
1.21% |
84 |
34.46% |
| 2016 |
1.17% |
87 |
33.00% |
| 2014 |
1.37% |
138 |
34.39% |
| 2015 |
1.28% |
147 |
32.69% |
| 2016 |
1.20% |
154 |
31.47% |
| 2014 |
3.56% |
74 |
93.80% |
| 2015 |
3.41% |
82 |
92.32% |
| 2016 |
3.35% |
90 |
91.13% |
| 2014 |
4.60% |
151 |
86.44% |
| 2015 |
4.42% |
159 |
84.13% |
| 2016 |
4.19% |
166 |
82.41% |
| 2014 |
5.28% |
38 |
88.04% |
| 2015 |
5.28% |
40 |
84.65% |
| 2016 |
4.58% |
42 |
82.41% |
| 2014 |
4.42% |
113 |
85.91% |
| 2015 |
4.19% |
119 |
83.95% |
| 2016 |
4.10% |
124 |
82.41% |
| 2014 |
1.40% |
921 |
33.90% |
| 2015 |
1.21% |
1.084 |
34.15% |
| 2016 |
1.01% |
1.128 |
31.89% |
Summary of Impairment Rates and Coverage Ratios (Adverse Scenario)
| Year |
Impairment Rate |
Stock of Provisions |
Coverage Ratio - Default Stock |
| 2014 |
1.85% |
24 |
41.44% |
| 2015 |
1.94% |
48 |
44.75% |
| 2016 |
2.01% |
72 |
48.48% |
| 2014 |
0.18% |
5 |
53.51% |
| 2015 |
0.17% |
8 |
50.28% |
| 2016 |
0.16% |
10 |
48.02% |
| 2014 |
7.34% |
700 |
33.67% |
| 2015 |
7.75% |
765 |
32.88% |
| 2016 |
7.05% |
806 |
32.51% |
| 2014 |
2.25% |
0 |
- |
| 2015 |
2.17% |
0 |
- |
| 2016 |
2.09% |
0 |
- |
| 2014 |
4.08% |
428 |
54.83% |
| 2015 |
4.25% |
466 |
51.76% |
| 2016 |
4.23% |
498 |
49.42% |
| 2014 |
2.67% |
225 |
40.72% |
| 2015 |
2.73% |
244 |
37.68% |
| 2016 |
2.98% |
260 |
35.62% |
| 2014 |
4.10% |
95 |
40.18% |
| 2015 |
4.26% |
103 |
37.48% |
| 2016 |
4.72% |
110 |
35.62% |
| 2014 |
2.22% |
130 |
40.61% |
| 2015 |
2.24% |
141 |
37.76% |
| 2016 |
2.34% |
151 |
35.63% |
| 2014 |
6.03% |
77 |
93.11% |
| 2015 |
6.30% |
85 |
91.20% |
| 2016 |
5.75% |
92 |
89.93% |
| 2014 |
7.74% |
157 |
85.05% |
| 2015 |
8.16% |
171 |
81.94% |
| 2016 |
7.38% |
182 |
80.04% |
| 2014 |
9.14% |
40 |
86.00% |
| 2015 |
10.94% |
44 |
81.27% |
| 2016 |
9.74% |
46 |
78.68% |
| 2014 |
4.42% |
88 |
87.41% |
| 2015 |
4.19% |
96 |
84.36% |
| 2016 |
4.10% |
102 |
82.36% |
| 2014 |
1.40% |
1,110 |
38.80% |
| 2015 |
1.21% |
1,236 |
37.75% |
| 2016 |
1.01% |
1,332 |
37.29% |
Summary of Key Findings
- Common Equity Tier 1 (CET1) Ratio:
- Baseline Scenario: 9.1% (as of 31 December 2016)
- Adverse Scenario: -0.5% (as of 31 December 2016)
- CET1 Threshold: 5.5% (Common EU-wide CET1 Threshold)
- Impairment Losses:
- Baseline Scenario: 187 mln EUR (as of 31 December 2016)
- Adverse Scenario: 529 mln EUR (as of 31 December 2016)
- Operating Profit Before Impairments:
- Baseline Scenario: 415 mln EUR (as of 31 December 2016)
- Adverse Scenario: 231 mln EUR (as of 31 December 2016)
- Total Risk Exposure:
- Baseline Scenario: 4,710 mln EUR (as of 31 December 2016)
- Adverse Scenario: 4,619 mln EUR (as of 31 December 2016)
- Risk Exposure Amounts:
- Baseline Scenario: 2,130 mln EUR (as of 31 December 2016)
- Adverse Scenario: 1,648 mln EUR (as of 31 December 2016)
- Value Adjustments and Provisions:
- Baseline Scenario: 55 mln EUR (as of 31 December 2016)
- Adverse Scenario: 771 mln EUR (as of 31 December 2016)
展开完整摘要
试读结束,高清完整版pdf/doc/ppt,请点下载